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Skeletal muscle, however, is able to regenerate after
injury because of the presence of satellite cells. The satel-
lite cell is a morphologically undifferentiated cell that lies
dormant between the plasma membrane and basal lamina
of mature skeletal muscle.3 When activated by appropriate
stimuli, satellite cells proliferate and differentiate into new
skeletal muscle fibers. We have been investigating “cellu-
lar cardiomyoplasty,” that is, the possibility of using satel-
lite cells to regenerate myocardium.4-6 If successful,
myocardial replacement with autologous skeletal mus-
cle–derived myoblasts has many advantages when com-
pared with other approaches for myocardial regeneration.
Autologous myoblasts do not require immunosuppression;
there is no potential for malignant transformation (which
is a risk when established cell lines are used); and ethical
and donor availability issues are not a concern (eg, use of
fetal cardiomyocytes). Our hypothesis is that satellite cells
transplanted into the myocardium will undergo “milieu-
dependent” differentiation into cardiac myocytes.6
T he lack of regenerative ability of adult mammalianmyocardium is a well-established fact.1,2 Stem cells
are absent from the myocardium, and the mature car-
diac myocyte is a terminally differentiated cell that has
been permanently withdrawn from the cell cycle. For
these 2 reasons, injury to the myocardium results in an
irreversible loss of cells and the injured area is replaced
by scar tissue.
Objective: Implanting myoblasts derived from autologous skeletal mus-
cle, that is, satellite cells, for myocardial replacement has many advan-
tages when compared with implanting either fetal cardiac myocytes
(ethical and donor availability issues) or established cell lines (onco-
genicity). Furthermore, autologous myoblasts do not require immuno-
suppression. The feasibility of satellite cell differentiation into muscle
fibers, after implantation into the myocardium, was confirmed by
means of a unique cell-labeling technique. Methods: Myoblasts (satellite
cells) isolated from the skeletal muscle of adult rats are labeled with
4´,6-diamidino-2-phenylindone, which binds to DNA and to the protein
tubulin to form a fluorescent complex, and implanted into the left ven-
tricular wall of isogenic rats. The specimens are harvested 1 to 4 weeks
after myoblast implantation. Histologic sections are examined under a
fluorescent microscope. Results: The labeling efficiency of satellite cells
with 4´,6-diamidino-2-phenylindole is nearly 100%. In 4 specimens, the
progressive differentiation of implanted myoblasts into fully developed
striated muscle fibers can be observed. Conclusion: Our earlier studies of
autologous myoblast implantation into the cryoinjured myocardium of
dogs suggested that these cells could differentiate into cardiac myocytes.
However, it had been difficult to firmly establish these findings with the
use of cell markers, thereby proving that the neomyocardium had
indeed been derived from the implanted myoblasts. In this study, using
4´,6-diamidino-2-phenylindole as a satellite cell marker, we were able to
demonstrate that the implanted satellite cells did in fact differentiate
into fully developed, labeled muscle fibers. Because of the obvious
advantages of using autologous donor myoblasts, the clinical application
of this approach may provide a novel strategy for the future manage-
ment of heart failure. (J Thorac Cardiovasc Surg 1998;116:744-51)
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Our previous work of implanting autologous satellite
cells into cryoinjured canine myocardium demonstrat-
ed the presence of striated muscle fibers at the implant
sites.4 This muscle showed morphologic characteristics
of cardiac myofibers, such as the centrally located
nuclei and intercalated disks. Nevertheless, our earlier
attempts to use a number of cell markers, such as 3H-
thymidine and the lacZ reporter gene, in an attempt to
confirm that such putative “neomyocardium” indeed
originated from the implanted myoblasts, had not been
entirely successful. In the present study, the satellite
cells were labeled with 4´,6-diamidino-2-phenylindole
(DAPI), a fluorescent dye that binds to both double-
stranded DNA (dsDNA) and the protein tubulin.7-9 This
labeling method enabled us to successfully follow, in
vivo, the full differentiation of satellite cells at the
implant sites.
Materials and methods
The animal model. As stated earlier, our goal is to study
the feasibility of autologous myoblast implantation for myo-
cardial regeneration. In our previous canine studies, myo-
blasts harvested from an animal were implanted into the
myocardium of the same animal. In the present study, the less
expensive but smaller isogenic rats were used as donors and
recipients, since as in the autoimplants, this model obviates
the need for immunosuppression.
Thirty male Lewis rats weighing 225 to 250 gm were used
in all experiments. As described in detail below, hind limb
skeletal muscle was explanted from the donor rats and used
as a source of satellite cells. The satellite cells were expand-
ed in culture for 7 to 10 days and labeled with DAPI just
before implantation into the myocardium of isogenic recipi-
ent rats. One to 4 weeks after implantation, the animals were
killed and hearts removed for histologic analysis. The entire
left ventricle was processed into 5 m m sections and every sec-
ond section examined under the fluorescent microscope. All
animals received humane care, and all experiments were per-
formed according to the “Guide to the Care and Use of
Experimental Animals” of the Canadian Council on Animal
Care and the “Guide for the Care and Use of Laboratory
Animals” (NIH publication No. 85-23, revised 1985).
Skeletal muscle explantation and satellite cell isolation.
After overdose with pentobarbital (100 mg/kg given intra-
peritoneally) (MTC Pharmaceuticals, Cambridge, Ontario,
Canada), the skeletal muscle of both hind quarters of adult
rats was excised. The muscle was rinsed with 70% ethyl alco-
hol for 30 seconds and then rinsed with 150 mL of Hanks bal-
anced salt solution (Gibco, Grand Island, NY). It was then
minced with scissors until a homogeneous mass was ob-
tained. After addition of 150 mL of Hanks balanced salt solu-
tion, muscle fragments were sedimented at 540g for 1
minute. The supernatant was discarded. This step was repeat-
ed 2 more times. The specimen was then incubated with 1%
collagenase (Sigma Chemical Co, St Louis, Mo) and 0.2%
type 1-S hyaluronidase in M199 solution (Gibco), supple-
mented with 5000 U/mL penicillin and 5000 m g/mL strepto-
mycin (Gibco) for 15 minutes at 37°C in a shaker bath.
Remaining muscle mass was then spun at 540g for 10 min-
utes. Released connective tissue elements were aspirated
with the supernatant and discarded. The muscle fragments
were then incubated with a 1% pronase solution (Sigma) for
15 minutes at 37°C to release satellite cells. The product ob-
tained was sedimented at 540g for 10 minutes and only the
supernatant containing released satellite cells was saved for
further manipulation. Fetal bovine serum (Gibco) was added
to the supernatant to halt further enzymatic cleavage processes.
The remaining tissue debris was separated from cells by
spinning the cell suspension at 775g for 15 minutes. The col-
lected cell pellet was washed and resuspended in the same
manner 4 times.
To purify the cell culture from fibroblasts present in the
final cell pellet, we used the density centrifugation method
described by Yablonka-Reuveni and Nameroff.10 In brief, the
cell suspension was layered on 20% colloidal polyvinyl-
pyrrolidonecoated silica (Percoll; Sigma), which itself rests
on a 60% Percoll layer. The whole liquid structure was cen-
trifuged at 15,000g for 5 minutes. The cell layer obtained at
the interface of the 20% and 60% Percoll concentrations con-
sisted mostly of satellite cells, whereas the majority of fibro-
blasts and other cells were situated within other layers at dif-
ferent levels. Retrieved satellite cells were counted on a
hematocytometer and their viability assessed by the trypan
blue exclusion test.
Satellite cell plating and passaging technique. Isolated
satellite cells were plated on 60 mm polystyrene tissue cul-
ture dishes (Corning, Inc, Corning, NY), which were coated
in advance with a layer of laminin (Sigma) to promote satel-
lite cell adherence. The plating density ranged from 5.0 · 105
to 7.5 · 105 cells per culture dish. Growth medium, each 100
mL composed of 82 mL of M199, 7.4 mL of minimal essen-
tial medium (Sigma), 10 mL of fetal bovine serum, 5000
U/mL of penicillin, 5000 m g/mL of streptomycin, 250 m L of
amphotericin B, and 40 m L of gentamicin, was replaced every
24 to 48 hours. Culture dishes were seeded with satellite cells
and were maintained in a 37°C humidified atmosphere of
95% air with 5% carbon dioxide.
To prevent satellite cells from premature differentiation
and fusion in vitro, frequent passaging (every 48 to 72 hours)
was carried out. During the passaging procedure, satellite
cells were subjected to a 30-second period of treatment with
trypsin (Gibco) diluted 10 times in M199. This measure facil-
itates detachment of cells from the tissue culture dishes.
Satellite cell labeling and implantation. On the day of
implantation, to culture dishes containing satellite cells, a
solution of 0.02% DAPI (Sigma) was added. The dye was
allowed to remain in the culture dishes for at least 30 min-
utes. The cells were rinsed at least 6 times in Hanks balanced
salt solution to remove all excess, unbound DAPI. Satellite
cells were then collected (approximately l · 106 cells) and
resuspended in 50 m L of M199.
Thirty male Lewis rats weighing 225 to 250 g served as the
recipients of the DAPI-labeled satellite cells. Anesthesia was
induced and maintained with isoflurane (MTC Pharma-
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ceuticals). Animals were intubated with an 18-gauge intra-
venous catheter and connected to a Harvard rodent ventilator
(Harvard Apparatus Co, Inc, South Natick, Mass) at 100
breaths/min. The heart was exposed via a 1.5 cm left thoracot-
omy incision. Under direct vision, the satellite cell suspension
was injected into the left ventricular wall with a 28-gauge nee-
dle. The thoracotomy was closed with 4-0 monofilament
sutures. The muscle and skin layers were closed with 4-0
absorbable sutures, and the animals were returned to their
cages. The operative mortality was 20% (6 animals), caused
by ventricular fibrillation after injection of satellite cells.
There were no late deaths.
Fluorescence microscopy. One to 4 weeks after implanta-
tion, animals were administered an overdose of pentobarbital
(100 mg/kg intraperitoneally). Each animal’s heart was
removed and fixed in 4% paraformaldehyde (Fisher
Scientific International Inc, Hampton, NH). The left ventricle
was isolated from the remainder of the heart and embedded
in paraffin. The entire left ventricle was sectioned into 5 m m
specimens and every second section was examined under the
fluorescent microscope (absorption at 350 nm, emission at
420 nm).
Results
The labeling efficiency of cultured satellite cells with
DAPI approached 100% (Fig 1). Culture of satellite
cells for up to 1 week, with DAPI added to the culture
medium, did not result in a decrease in cell viability.
Gross examination of the intact specimen did not
reveal any structural abnormalities. The implant site
was not evident. Microscopic analysis revealed 4 spec-
imens in which fluorescent cells were identified within
the host myocardium. Two specimens were obtained 1
week after implantation and another 2 specimens were
obtained 4 weeks after implantation. At 1 week, a mass
of fluorescent cells was found at 1 discrete location
within the host myocardium (Fig 2). Their primitive
structure would imply that these are satellite cells at the
original implant site that have not yet differentiated.
Near the implant site, however, fluorescent cells with
the same structure as the surrounding myocytes were
identified (Fig 3). The fluorescent fibers were aligned
with the host myocytes. The nucleus of these labeled
muscle fibers is centrally located.
At 4 weeks, the undifferentiated cells were no longer
present. However, the number of labeled muscle fibers
was much greater. As already described, the structure
of the labeled cells was the same as that of the sur-
rounding myocytes, and these cells were always
aligned with the host myocytes (Fig 3). In the remain-
ing 20 specimens, fluorescent cells were not identified
anywhere in the myocardium.
Discussion
The myocardium develops from cells of the precar-
diac mesoderm. Differentiation of mesodermal cells
into cardiomyocytes is completed very early during
development.1 Growth of myocytes in the embryo con-
sists of hyperplasia of the existing, differentiated cells.
In the early postnatal period, the enzymes needed for
DNA synthesis are turned off and the proliferative
capacity of the cardiac myocyte is lost.1
The lack of proliferative ability of existing myocytes,
coupled with the absence of stem cells, accounts for the
fact that the myocardium of adult mammals is not able
to regenerate. Injury to a portion of the mammalian
heart results in an irreversible loss of cells and a per-
manent loss of function. Transplantation of exogenous
cells into the heart is one potential therapeutic
Fig 1. Cultured satellite cells stained with DAPI. Note that virtually 100% of the cultured cells are labeled.
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approach for repair of damaged myocardium. The
rationale of this strategy is that an increase in the num-
ber of muscle fibers will result in an improvement of
overall function. A number of cell types are available
and have already been used for this purpose.
Cardiomyocyte and skeletal myoblast cell lines form
stable grafts when transplanted into the myocardi-
um.11-13 However, the drawback of these cell types is
their potential for malignant transformation. Fetal car-
diomyocytes also form stable intracardiac grafts14-16
and have been shown to couple with host cells via
intercalated disks.17 Fetal skeletal myoblasts can also
establish new contractile tissue when, transplanted into
the myocardium, these grafts convert to fatigue-resis-
tant, slow-twitch fibers that may be more suited to a
cardiac workload.18 However, the ethical issues in-
volved in the use of fetal tissues would likely limit their
practical application.
The satellite cell of skeletal muscle has many proper-
ties that make it the ideal cell for restoring lost cardiac
Fig 3. Labeled muscle fibers within host myocardium 1 week after satellite cell implantation. Four fluorescent
cells are found clustered together but are interspersed by an unlabeled (host) myocyte. Fluorescent cells have the
same structure as the surrounding native myocytes. Similar findings were obtained 4 weeks after satellite cell
implantation.
Fig 2. Labeled cells within the host myocardium 1 week after satellite cell implantation. Note undifferentiated
appearance of the cells. Location within the myocardium most likely corresponds to the implant site.
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muscle. Satellite cells are easily obtainable and, inas-
much as they are primary cells, there is no potential for
malignant transformation. Satellite cell transplants are
autologous; therefore there is no need for immunosup-
pression and there are no ethical concerns related to the
use of fetal tissues. Our hypothesis is that this cell will
differentiate into a cardiac myocyte, under appropriate
conditions, when transplanted into the heart.
In our first series of experiments, the satellite cells
were labeled with 3H-thymidine before implantation
into acutely cryoinjured myocardium. Gross examina-
tion of the implant site revealed muscle-like tissue, and
histologic analysis confirmed the presence of striated
cells connected by intercalated disks (Fig 4).4
However, autoradiographic evaluation of this tissue
revealed a labeling intensity almost indistinguishable
from background. Marker dilution associated with
multiple cell replications before differentiation is a
possibility. Attempts to increase initial labeling con-
centration could perhaps cause radiation injury of the
nuclei. In any event, failure to follow the 3H-thymi-
dine–labeled satellite cells in vivo did not allow for
definitive validation of our original hypothesis and
prompted us to use an artificially constructed DNA
plasmid as a satellite cell marker.
In a second attempt, satellite cells were transfected
with a plasmid carrying the lacZ reporter gene, which
codes for b -galactosidase, and then implanted into
acutely cryoinjured myocardium.4 The results of these
experiments demonstrated b -galactosidase activity
within the tissue at the implant site. Inasmuch as the
satellite cells were transfected with the gene coding for
this enzyme before implantation, this finding confirmed
that the satellite cells survived (Fig 5). Unfortunately, so
far we have been unsuccessful in demonstrating satellite
cell differentiation into fully developed muscle fibers.
Failure to detect labeled muscle fibers at the implant
site may be due to altered expression of the lacZ
reporter gene by fully differentiated muscle fibers, per-
haps caused by the loss of the genes or their promoters.
Another concern with the use of this particular plasmid
construct was that the transfection efficiency of satellite
cells was quite low (10%-20%).
Thus our previous work confirmed survival of the
implanted, labeled satellite cells. Furthermore, striated
muscle fibers were demonstrated histologically at the
original satellite cell implant site.4,19 Nevertheless,
definitive proof of “milieu-dependent” satellite cell dif-
ferentiation was not achieved owing to the absence of
fully developed muscle fibers carrying the original satel-
lite cell marker. In a continued effort to validate our orig-
inal hypothesis, we sought a new satellite cell marker
that would ideally have the following properties: (1)
high labeling efficiency, (2) expression of cell marker
not altered by state of differentiation of a cell, and (3)
stable cell marker retained by satellite cells throughout
Image not available
Fig 4. Histologic study of tissue found at the implantation site, after auto-implantation of canine satellite cells
into the myocardial cryolesion. The arrow points to an intercalated disk unique to cardiac myofibers. (From Chiu
RC-J, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation.
Reprinted with permission from the Society of Thoracic Surgeons, The Annals of Thoracic Surgery 1995;60:12-8
[Fig 4]).
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their development in vivo. DAPI is a fluorescent dye that
labels the nucleus of a cell because of its high affinity for
dsDNA.8 Its mechanism of action is that it forms strong
electrostatic interactions with adenine-thymine rich
regions of DNA. The fluorescence quantum yield of the
free dye is very low, but its binding to DNA results in a
highly fluorescent complex. The other cell component to
which DAPI binds to form a fluorescent complex is the
protein tubulin.9 DAPI is nontoxic to living cells and
does not alter the ultrastructure of cell organelles.7
To further validate the use of DAPI as the cell mark-
er for our study, we did additional experiments to expel
the concern that some leakage of the dye into the sur-
rounding milieu could give false positive results. Ac-
cordingly, we injected DAPI solution directly into the
muscle to see whether in vivo uptake would occur. As
Fig 6. Direct injection of DAPI solution into a muscle tissue in vivo failed to show uptake of DAPI fluorescence
in a specimen obtained 1 week after injection.
Image not available
Fig 5. Implanted satellite cells encoded with the lacZ reporter gene; note b -galactosidase activity at the implant
site within the myocardium. (From Chiu RC-J, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regen-
eration with satellite cell implantation. Reprinted with permission from the Society of Thoracic Surgeons, The
Annals of Thoracic Surgery 1995;60:12-8 [Fig 6]).
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shown in Fig 6, no muscle fiber with positive DAPI
fluorescence was noted. It is likely that this is due to
the rapid washout of injected dye from the tissue by the
blood flow, which did not allow sufficient time for
DAPI to bind to the DNA in the nuclei. As mentioned
earlier, the DAPI solution is incubated in vitro with
cultured cells for a period of 30 minutes or more in our
study, as well as those by others.7 The excess dye in the
cultured media was removed before cell implantation.
If DAPI can label satellite cells in vitro without pre-
venting the labeled cells from differentiating, it is rea-
sonable to expect that implantation of such cells into
skeletal muscle should produce skeletal muscle fibers
with labeled nuclei. Such an experiment was also car-
ried out as another step in validating our method. As
shown in Fig 7, 4 weeks after the implantation of
DAPI-labeled satellite cells into the skeletal muscle,
labeled multinucleated muscle fibers were seen in the
specimen. These fibers contained spindle-shaped
nuclei located in the periphery of the muscle fibers,
demonstrating morphologic characteristics of skeletal
muscle fibers, which are distinct from those seen in Fig
3. The specimen shown in Fig 3 is taken from
myocardium, and the labeled muscle fibers seen con-
tain vesicular and centrally located nuclei, similar to
those in the cardiac muscle fibers.
In this study, the satellite cells were injected into the
beating heart with a needle in an open chest rat.
Because the needle hole was not sealed, it is possible
that much of the implanted cells had been squeezed out
from the ventricular wall during systolic compression
by the surrounding muscle fibers. This may explain in
part why we found only 4 hearts with positively labeled
myofibers out of 20 implantations. To achieve greater
consistency, we are pursuing further refinement and
optimization of culture and implantation techniques.
Conclusion
Our results indicate that DAPI is a useful marker to
follow the development of satellite cells in vivo. The
dye is stably incorporated by the satellite cell and per-
sists within the cell throughout its development within
the host myocardium. Using DAPI as a marker, we were
again able to confirm satellite cell survival within the
myocardium. Furthermore, our finding of labeled, fully
differentiated muscle fibers strengthens and supports
the hypothesis that skeletal myoblasts do in fact differ-
entiate into muscle fibers after transplantation into the
myocardium. Our earlier morphologic studies also indi-
cated that such new tissue may express phenotypes
ranging from those of cardiac, skeletal, and even
“mosaic” muscle fibers, depending on the culture and
implant conditions.6 Further phenotype characterization
at the molecular level is currently being undertaken
with the use of phenotype-specific monoclonal antibod-
ies.
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Discussion
Dr Juan C. Chachques (Paris, France). I want to con-
gratulate the group of Dr Chiu for this continued work in cel-
lular cardiomyoplasty. The European Union selected our
group at Broussais Hospital in Paris to develop a similar cell
implant program, which we call “dynamic cellular cardiomy-
oplasty,” because we think that the implanted cell must con-
tribute to myocardial contractility. 
I have 2 questions. First, do you think that the myocardial
depolarization will be sufficient to induce contraction of your
implanted cells, or perhaps in the future would it be necessary
to electrically stimulate this new tissue? Second, concerning
the cells marked with DAPI, it will be interesting to know
whether this product will be released and whether there is a
risk of toxicity for the cell itself.
Dr Dorfman. I think it is possible that these cells can cou-
ple with the surrounding myocytes. In a work published in
1996, in which myoblast cell lines were implanted into the
myocardium, the investigators found structures that looked
like gap junctions between the implanted and the native
myocytes, and they were able also to stain for connexin-43,
which is a gap junction at the interface of the implanted and
host myocytes.
In answer to your second question, this marker works by
diffusing into the cell down its concentration gradient and
forming a very strong electrostatic interaction with dsDNA.
We cultured cells with this dye for a long time. It is stably
retained by the cell even at very high concentrations, and it is
not toxic to the cell. It can also bind to other components of
the cell. For example, it binds with tubulins with which it also
fluoresces. When it binds to RNA, however, the complex is
not fluorescent. The free dye itself is also not fluorescent. It
is very specific for dsDNA and for tubulins.
Mr Magdi Yacoub (London, United Kingdom). Central to
your hypothesis is the expression by these cells of myocardi-
um-specific functional type proteins, for example, dihy-
dropteridine, myocardium-specific isoforms, or gap junctions
specific to the myocardium such as connexin-43. Can you
reassure us that these indeed are myocytes rather than skele-
tal type cells, which are two different things? 
Dr Dorfman. No, we have not reached that stage yet to
determine the exact phenotype of these cells.
Dr Eric A. Rose (New York, NY). I will ask what I think
would be the question of the Toronto group: They are telling
us now that the terminal differentiation “religion” that we are
working with is incorrect, that myocytes can be isolated and
propagated in culture. Have you tried to do that? 
Dr Dorfman. We have not tried to do that, because from
my research and from reading the literature, I was convinced
that the cardiac myocyte is truly a terminally differentiated
cell. If these cells could be propagated in culture, I would be
concerned about them being transformed in some way.
Dr Alain F. Carpentier (Paris, France). Why did you not
use cryoinjury before the implantation of the cells? Were you
afraid of fibrous proliferation? What is your rationale for not
trying to mimic myocardial injury?
Dr Dorfman. I wanted the satellite cells to be exposed as
much as possible to the cardiac environment rather than in a
scar that contains fibroblasts and inflammatory cells. I
thought that would give me the greatest chance for success.
